Skip to main content
OpenTrials
Completed

NCT Number: NCT01197742

Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction

The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Cardiovascular Diseases Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Heart Diseases Infarction Ischemia Metabolic Diseases Myocardial Infarction Myocardial Ischemia NSTEMI Necrosis Non-ST Elevated Myocardial Infarction Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction STEMI Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Städ Krankenhaus münchen Schwabing, München, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction
  • consecutive patients with acute (no older than 24 h) Non-ST-Elevation Myocardial infarction

Exclusion criteria

  • missing informed consent

Treatment and study plan

Primary outcomes

  1. Documentation of the characteristics consecutive patients with acute STEMI or NSTEMI in daily hospital routine in Germany

    Time frame: 04/01/2007-09/30/2009

Secondary outcomes

  1. Documentation of the fraction of patients with (I) a previous know Diabetes Mellitus (DM) type I and II, (II) a newly diagnosed DM, (III) diagnosed with IFG or IGT for the first time

    Time frame: 04/01/2007-09/30/2009

  2. Documentation of acute invasive and adjuvant medicamentous therapy of STEMI and NSREMI in hospital daily routine in Germany

    Time frame: 04/01/2007-09/30/2009

  3. Documentation of diabetic therapy during the acute phase of a myocardial infarction

    Time frame: 04/01/2007-09/30/2009

  4. Documentation of the hospital mortality, the serious but non-fatal complications (stroke, re-myocardial infarction) and other bleeding complications

    Time frame: 04/01/2007-09/30/2009

  5. Verification of the implementation of a therapy according to the guidelines for STEMI / NSTEMI in daily hospital routine

    Time frame: 04/01/2007-09/30/2009

Sponsors and collaborators

Lead sponsor

Stiftung Institut fuer Herzinfarktforschung

Other

Collaborators

  • Sanofi

Registry information

Official study title

Sweetheart: Risiko-Management Von Diabetikern Mit Akutem Myokardinfarkt

Acronym: Sweetheart

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Sep 9, 2010
Registry last updated
Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.